Thursday, December 3, 2020

Ahead of vaccine approvals, Interpol blows the whistle on would-be scammers

The NPC Healthbiz Weekly has launched. It's your weekly briefing on topics pertinent to healthcare marketers and executives published in cooperation with Peak Pharma Solutions. From Chronicle Companies, organizers of the National Pharmaceutical Congress. More info at pharmacongress.info

⇒ Issue #144 (In numerology, 144 symbolizes new beginnings, efforts, diligence, and determination.)
⇒ Confirmed Covid cases in Canada as of 12/02: 
393,506*
⇒ Confirmed Covid fatalities in Canada as of 12/02: 12,342*
⇒ Worldwide Covid cases as of 12/02: 64,648,033*
⇒ Worldwide Covid fatalities as of 12/02: 1,495,919*

December 3, 2020—Good morning, CurveFlatteners, and we extend a special warm welcome to everyone onboard DCF Flight 144 this morning. We're en route for the next few months and will arrive on time at destination Inoculation -- with just a quick stopover to pick up connecting passengers in Vaccine Logistics Hell. Here in the cockpit, it’s Mitch Shannon, ably assisted today by our flighty crew. Uh, I meant to say, flight crew.

Yesterday (12/02), the U.K. approved the emergency use of the Pfizer-BioNTech vaccine and will begin to make it available to frontline medical workers and geriatric patients in care institutions across the country by next week. Britain is among the first countries to make vaccinations available. Said Pfizer kingpin Dr. Albert Bourla: “With thousands of people becoming infected, every day matters in the collective race to end this devastating pandemic.” U.S. FDA and Health Canada approvals seem likely to follow before year-end.


And arriving just a few minutes ahead of the vaccine shipments, who do we find but the grifters and scam-artists? The Paris-based International Criminal Police Organization (known to the 194 participating national security forces as Interpol) issued an alert to worldwide law-enforcement agencies that racketeers are out to steal vaccine supplies or sell counterfeit versions. Interpol says the threats may appear in both physical and online forms. The virtual scams carry a double-whammy: Interpol’s cybercrimes unit found nearly 60 per cent of online drugstores suspected of selling illegal remedies also placed malware on shoppers’ devices, posing a further risk. Says Interpol’s top cop Jürgen Stock: “It is essential that law enforcement is as prepared as possible for what will be an onslaught of all types of criminal activity linked to the Covid-19 vaccine.” He also warns of a proliferation of fake test kits.


With all those goniffs hanging around the seedy corners of cyberspace plotting crimes, it should reassure Canadians that our federal government just re-awarded itself the authority to spend unlimited sums on no-bid contracts to sole sources, with little oversight or scrutiny. Ottawa has not been forthcoming about details of acquisitions made through the Public Services and Procurement ministry, despite requests from media outlets through the Access to Information Act. Among the known sole-source contracts awarded was a $381.7 million payday to AMD Medicom Inc. of Pointe-Claire, Que., for N95 surgical masks. Minister Anita Anand says she won’t be surprised if some of the goods she’s acquiring from foreign sources fall short of expectations, owing to a sellers’ market for PPE. Her deputy minister, Bill Matthews, summed up the attitude this way: “I have instructed the department to take risks in purchasing PPE. The situation we face requires bold, aggressive action. However, moving decisively and quickly does carry certain risks." Whew. Talk about the very opposite of driving a hard bargain. Now let’s see how long it takes to gather tough kids to take away Anita and Bill’s (unlimited) lunch money. Which is not theirs, of course. It's ours.

The NPC Podcast is back for another season. The organizers of the National Pharmaceutical Congress are proud to release our new weekly podcast series, hosted by Peter Brenders. Peter's guest this week is Mark Lievonen. Listen
 here now, or download the episode and play it at your convenience. The NPC Podcast is presented in cooperation with Impres Pharma


COVID CHRONICLE 12-03-20

  • Parkinson’s disease may be one more CNS comorbidity associated with Covid infection, according to research just published in Lancet Neurology. Prof. Marcelo Merello of Buenos Aires, Argentina and colleagues found about two-thirds of Covid patients present with hyposmia, a common premotor symptom in Parkinson's disease. The authors note, “the hypothetical possibility that a viral infection might trigger a series of processes that result in the development of Parkinson's disease over the long term in individuals with genetic susceptibility.”

    • Who goes first? That’s always the question in experimental medicine, as well as being the title of an enjoyable book by Dr. Lawrence K. AltmanAn advisory committee of the U.S. Centers for Disease Control and Prevention recommended Tuesday (12/01) that medical workers and geriatric patients in care institutions be the first to receive a coronavirus vaccine. The panel ruling parallels that of the U.K. (see previous item) and comes in advance of any FDA approval. Public health officials predict there won’t be sufficient supplies of vaccines available for the entire country until well into the midway point of 2021. The panel defined “medical workers” broadly, to include administrative and support staff and operational teams such as catering. Approximately 24 million such workers will qualify for early vaccination.

    • In contrast to the USA’s abdication of global leadership on combating the Covid pandemic and its rejection of the World Health Organization, the Peoples’ Republic of China has stepped up and is pledging to make its domestically developed vaccines available to developing nations. Four Chinese biotech groups have created five candidate vaccines and are enrolling Phase III trial participants in 16 countries, reports CNN. Unlike vaccines developed in the west by companies such as Pfizer and Moderna, the Chinese candidates do not require sub-zero storage, simplifying logistics and distribution. Further unlike the other vaccines, none of the developers have released safety or efficacy data to date.


    TODAY CHRONICLE IS WORKING ON

    The first day of the Real World Medicannabis symposium kicks off this evening at 7:30 p.m. EST, featuring a stellar faculty and more than 250 registered delegates. The second session will be held Saturday, Dec. 5. Register at http://realworld.events



    LATER I'M READING

    There's something inexplicably satisfying about author Jon Talton's series of crime novels set in Maricopa County, Arizona, which depict a middle-aged detective who is a failed academician with a doctorate in history. The latest effort from 2018 is a retelling of the actual killing in Phoenix
    40 years ago of investigative reporter Don Bolles (here fictionalized as "Chip Page.") The Bomb Shelter may be the richest of Talton's dozen novels, with its recurring motifs of lost pleasures, lost possibilities, and the lost civilization that was the small, genteel city of Phoenix in the mid-20th century.



    TILL FRIDAY

    Tomorrow Chronicle Senior Editor John Evans, known as the Champ from Chauncy Street, will pick up the Covid coverage.


    No comments:

    Post a Comment

    Thanks for posting a comment. Your remarks are waiting for confirmation, which may take a little while. Check back frequently